TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pfizer Health AB
Closing information (x1000 DKK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
2,856,768
|
4,123,005
|
2,884,443 |
| Financial expenses |
1,942
|
0
|
681 |
| Earnings before taxes |
1,336,439
|
2,571,498
|
1,832,894 |
| EBITDA |
1,376,584
|
2,576,063
|
1,915,929 |
| Total assets |
5,214,962
|
7,188,194
|
6,567,928 |
| Current assets |
3,598,803
|
5,589,730
|
4,922,202 |
| Current liabilities |
745,919
|
793,688
|
546,533 |
| Equity capital |
4,307,957
|
6,260,629
|
5,879,636 |
| - share capital |
1,656,304
|
1,668,245
|
1,741,011 |
| Employees (average) |
337
|
340
|
325 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
82.6%
|
87.1%
|
89.5% |
| Turnover per employee |
8,477
|
12,126
|
8,875 |
| Profit as a percentage of turnover |
46.8%
|
62.4%
|
63.5% |
| Return on assets (ROA) |
25.7%
|
35.8%
|
27.9% |
| Current ratio |
482.5%
|
704.3%
|
900.6% |
| Return on equity (ROE) |
31.0%
|
41.1%
|
31.2% |
| Change turnover |
-1,236,724
|
1,359,118
|
684,698 |
| Change turnover % |
-30%
|
49%
|
31% |
| Chg. No. of employees |
-3
|
15
|
14 |
| Chg. No. of employees % |
-1%
|
5%
|
5% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.